Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Interactive:
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Quiz
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Exams
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Rheumatology


Answer 4
  1. Allopurinol and azathioprine. Allopurinol is the most commonly used urate-lowering drug and is generally well tolerated. However, allopurinol should be used with extreme caution in patients who are taking azathioprine. Allopurinol works by inhibiting xanthine oxidase, thus blocking purine metabolism. Azathioprine is a purine analogue that is metabolized by the xanthine oxidase pathway. Blood levels of azathioprine increase markedly in the context of allopurinol administration and can cause granulocytopenia. When allopurinol and azathioprine are administered together, the dose of azathioprine should be decreased by 50% to 75%, with close monitoring of the leukocyte count.

Click here to return to the questions

 

Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj